52 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
52 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
52 DaysReady to play
Ready to play
A US study has shown that an experimental vaccine called "SchistoShield" successfully elicited a strong immune response and generated long-lasting immune memory against schistosomiasis, a parasitic disease that is spread across approximately 80 countries and affects around 250 million people worldwide. Clinical trials demonstrated that the vaccine stimulates cellular immune responses as well as memory cells of both B and T lymphocytes, which enhances the likelihood of sustained protection against the parasites. The next step involves conducting larger-scale trials to verify its effectiveness and safety on a broader level.
Notice: This Is an AI-Generated Summary
Comments (0)